These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8091344)

  • 1. [Effects of PAF antagonists in experimental models. Therapeutical perspectives].
    Desquand S
    Therapie; 1993; 48(6):585-97. PubMed ID: 8091344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet-activating factor (PAF) and PAF antagonists in asthma.
    Hosford D; Mencia-Huerta JM; Braquet P
    Crit Rev Ther Drug Carrier Syst; 1990; 7(3):261-73. PubMed ID: 2073689
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists.
    Lellouch-Tubiana A; Lefort J; Simon MT; Pfister A; Vargaftig BB
    Am Rev Respir Dis; 1988 Apr; 137(4):948-54. PubMed ID: 3281530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of hetrazepine PAF antagonists in preclinical models of asthma.
    Heuer HO
    Agents Actions Suppl; 1991; 34():229-45. PubMed ID: 1793067
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is platelet-activating factor involved in bronchopulmonary hyperresponsiveness?
    Lefort J; Pretolani M; Desquand S; Vargaftig BB
    J Lipid Mediat; 1992; 5(2):163-7. PubMed ID: 1525358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in platelet-activating factor receptor mediated Ca++ response between hamster and guinea pig alveolar macrophages.
    Chen J; Giri SN
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1047-58. PubMed ID: 9190835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of platelet activating factor and its antagonists in bronchial asthma].
    Massion PB; Frans A
    Rev Pneumol Clin; 1992; 48(2):49-57. PubMed ID: 1384101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rupatadine, a new potent, orally active dual antagonist of histamine and platelet-activating factor (PAF).
    Merlos M; Giral M; Balsa D; Ferrando R; Queralt M; Puigdemont A; García-Rafanell J; Forn J
    J Pharmacol Exp Ther; 1997 Jan; 280(1):114-21. PubMed ID: 8996188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Compound PCA-4248 interferes with bronchopulmonary anaphylaxis and with in vitro hyperresponsiveness to platelet-activating factor.
    Desquand S; Ruffié C; Lefort J; Hatmi M; Pina M; Priego JG; Vargaftig BB
    Eur J Pharmacol; 1993 Apr; 235(1):101-8. PubMed ID: 7686102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet Activating Factor antagonists.
    Afroz S; Ara A; Arif M
    Pak J Pharm Sci; 1998 Jul; 11(2):5-12. PubMed ID: 16414813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candidate's thesis: Platelet-activating factor-induced hearing loss: mediated by nitric oxide?
    Rhee CK
    Laryngoscope; 2003 Dec; 113(12):2059-66. PubMed ID: 14660903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats.
    Akagi M; Nishioka E; Kanoh R; Tachibana M; Fukuishi N
    Arzneimittelforschung; 1997 Dec; 47(12):1364-9. PubMed ID: 9450165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Platelet-activating factor (PAF)-antagonists of natural origin.
    Singh P; Singh IN; Mondal SC; Singh L; Garg VK
    Fitoterapia; 2013 Jan; 84():180-201. PubMed ID: 23160091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet-activating factor and shock.
    Feuerstein G; Siren AL
    Prog Biochem Pharmacol; 1988; 22():181-90. PubMed ID: 3043432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet activating factor and its role in trauma, shock, and sepsis.
    Ayala A; Chaudry IH
    New Horiz; 1996 May; 4(2):265-75. PubMed ID: 8774801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The booster injection of antigen during active sensitization of guinea-pig modifies the anti-anaphylactic activity of the PAF antagonist WEB 2086.
    Desquand S; Lefort J; Dumarey C; Vargaftig BB
    Br J Pharmacol; 1990 Jun; 100(2):217-22. PubMed ID: 2379029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiasthma activity of the novel antihistamine E-4716 in guinea pigs in vivo.
    Cortijo J; Farré AJ; Gutierrez B; Morcillo EJ
    Methods Find Exp Clin Pharmacol; 1996 Sep; 18(7):465-73. PubMed ID: 8900220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of Asthremedin on bronchial hyperresponsiveness (BHR) to histamine induced by intravenous administration of platelet activating factor (PAF) in guinea pigs].
    Tsukagoshi H; Kurosawa M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Mar; 31(3):310-6. PubMed ID: 8391092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Platelet activating factor (PAF). A review of its effects, antagonists and possible future clinical implications (Part I).
    Koltai M; Hosford D; Guinot P; Esanu A; Braquet P
    Drugs; 1991 Jul; 42(1):9-29. PubMed ID: 1718687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric effects of PAF.
    Esplugues JV; Whittle BJ
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():61-6. PubMed ID: 2657290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.